Since HDAC (HDAC1, HDAC2) expression and activity are frequently increased in cancers and that epigenetics has been shown to be crucial in cancer biology, the project to use HDACis to fight cancer progression emerged more than 15 years ago. Here, HDAC9 is linked to cancer.